Subtype Reproducibility

Subtype Reproducibility is the extent to which a derived disease subtype can be consistently identified across independent studies, datasets, or analytical methods, thereby distinguishing it from spurious or study-specific classifications within the broader class of disease subtyping validation metrics.

35

Publications

2.8K

Citations

346

Authors

173

Institutions

Publications per year

2017–2026

11

Authors

346

  1. PS
    Philip S. Bernard

    University of Utah, United States

    2 publications · 46 citations

    2

    h-index

  2. SY
    Seo Young Park

    University of Ulsan, South Korea

    1 publications · 30 citations

    1

    h-index

  3. CW
    Costan W. Berard

    National Cancer Institute, United States

    1 publications · 30 citations

    1

    h-index

  4. CJ
    Chong Jin

    University of North Carolina at Chapel Hill, United States

    1 publications · 238 citations

    1

    h-index

  5. KH
    Kenichi Harigaya

    Chiba University, Japan

    1 publications · 195 citations

    1

    h-index

1–5 of 346

Venues

  1. Clinical Cancer Research

    3 publications · 374 citations

    3

    h-index

  2. Journal of Clinical Microbiology

    JCM · 3 publications · 131 citations

    3

    h-index

  3. Neuro-Oncology

    2 publications · 33 citations

    2

    h-index

  4. PLoS ONE

    2 publications · 39 citations

    2

    h-index

  5. JNCI Journal of the National Cancer Institute

    2 publications · 238 citations

    2

    h-index

1–5